Asia Pacific Non-Invasive Cardiac Output Monitoring Device Market to Grow at a CAGR of 5.5% to reach US$ 72,964.07 thousand from 2020 to 2027

The Asia Pacific non-invasive cardiac output monitoring device market is expected to reach US$ 72,964.07 thousand by 2027 from US$ 50,179.39 thousand in 2020; it is expected to grow at a CAGR of 5.5% from 2020 to 2027.

The growth of the market is attributed to a few key driving factors such as increase in prevalence of cardiovascular diseases and growth potential in developing nations. However, the high cost of the device hinders the market growth.

In recent years, many minimally invasive or non-invasive devices have been developed to measure cardiac output (CO), which is essential in a medical practice. Cardiac output gives information about tissue perfusion and oxygen delivery as well as can identify patients who are at high risk of mortality or morbidity. The prevalence of chronic diseases is increasing, especially in developing countries such as India and China. In addition, the incidence of cardiovascular conditions is rising mainly due to the shift in lifestyle and other factors such as the high smoking consumption and unhealthy diet. Thus, the growing prevalence of CVD is boosting the adoption of non-invasive cardiac output monitoring devices, thereby fueling the growth of the Asia Pacific non-invasive cardiac output monitoring device market.Developing nations are significantly developing their healthcare facilities and services and are heading toward technological advancements. For instance, as per the Ministry of Commerce & Industry, Government of India, the healthcare market is expected to increase three-fold to reach ~US$ 133.44 billion (INR 8.6 trillion) by 2022. Also, medical tourism is growing at a notable pace in Asia Pacific countries. Thus, the developing nations hold significant opportunities for the non-invasive cardiac output monitoring device providers to enter the market with cost-effective products, which is likely to boost the market growth during the forecast period.

Countries in Asia Pacific are expecting to witness massive challenges due to the COVID-19 outbreak. Considering the economic operations and geographic conditions, the pandemic has adversely affected medical tourism and medical equipment manufacturing. It also caused other problems due to the shortage of healthcare infrastructure in Asia-Pacific low-income countries. The cardiac monitoring devices are a part of critical care and have high demand during the pandemic. The non-invasive monitoring devices are proving helpful to monitor the patients suffering from COVID-19. At-home medical care is being preferred by patients who do not require hospitalization, and the increasing adoption of telehealth care facilities is expected to support the Asia Pacific non-invasive cardiac output monitoring device market in coming years. Thus, it is likely to offer lucrative opportunities for the market to bring its economy on track.

ASIA PACIFIC NON-INVASIVE CARDIAC OUTPUT MONITORING DEVICE MARKET SEGMENTATION

By Device

• Patches
• Wristwatches
• Probes & Catheters

By Indication

• Hypertension
• Coronary Diseases
• Congenital Problems
• Myocardial Ischemia and Infarction
• Heart Failure
• Arrhythmias
• Others

By End User

• Hospitals
• Emergency Services Centers
• Homecare
• Others

By Country

• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia Pacific

Company Profiles

• General Electric Company
• Koninklijke Philips N.V.
• Abbott
• DELTEX MEDICAL
• CONMED Corporation
• NIMedical
• Baxter International Inc.

Asia Pacific Non-Invasive Cardiac Output Monitoring Device Report Scope